Clopidogrel is an antiplatelet agent that is often used in combination with aspirin to help reduce the risk of an MI.
The risk of bleed is a high priority with the use of clopidogrel. Patients must be monitored for signs and symptoms of bleeding and bruising.
Clopidogrel is a prodrug that is converted to its active metabolite by CYP2C19.
Fluconazole can inhibit CYP2C19 which may reduce the effectiveness of clopidogrel.
Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!